Eris Lifesciences Limited — Investor Meet, 26-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

The call covered the financial results for the quarter and year ended March 31, 2025, focusing on revenue growth, profitability, and operations. Management emphasized expanding market presence and product portfolio as key priorities. Analyst questions on margin outlook and growth drivers were addressed, with management expressing confidence in steady momentum and execution.